4 Form 4 filings for MAZE between 2026-08-05 and 2026-08-17, from 4 filers. 4 discretionary (1 sales, 1 purchases). 1 of 4 state a filing-level total, summing to $922,315; the rest report only their largest transaction, so the true figure is higher. Prices ran $10 to $27.
| Filed | Filer | Role | Action | Shares largest txn | Price | Filing total | Txns |
|---|---|---|---|---|---|---|---|
| 2026-08-17 | Kornowski Sophie (Director at Maze Therapeutics, Inc.) filed a Form 4; no parseable transaction details were found in the filing. | ||||||
| 2026-08-17 | Johnson Paula A (Director at Maze Therapeutics, Inc.) filed a Form 4; no parseable transaction details were found in the filing. | ||||||
| 2026-08-14 | Bernstein Harold | acquired | 16,142 | $10.42 | — | 2 | |
| 2026-08-05 | Coloma Jason V | Chief Executive Officer | sold | 30,304 | $26.71 | $922,315 | 4 |
| 4 filings · 4 filers · disclosed totals only | $922,315 (1/4) | — | |||||